Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma.

Rodríguez-Nogales, Carlos; Moreno, Haritz; Zandueta, Carolina; Desmaële, Didier; Lecanda, Fernando; Couvreur, Patrick; Blanco-Prieto, María J

Rodríguez-Nogales, Carlos; Moreno, Haritz; Zandueta, Carolina; Desmaële, Didier; Lecanda, Fernando; Couvreur, Patrick; Blanco-Prieto, María J.

Afiliação

Rodríguez-Nogales C; Chemistry and Pharmaceutical Technology Department, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain.
Moreno H; IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Zandueta C; IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Desmaële D; Solid Tumors Program, Division of Oncology, Centre for Applied Biomedical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
Lecanda F; IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Couvreur P; Solid Tumors Program, Division of Oncology, Centre for Applied Biomedical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
Blanco-Prieto MJ; Institut Galien Paris Sud, CNRS UMR 8612, Université Paris-Saclay, 92296 Châtenay-Malabry, France.

Cancers (Basel) ; 12(7)2020 Jul 14.

Article em En | MEDLINE | ID: mdl-32674353

Palavras-chave

chemotherapy; edelfosine; gemcitabine; metastasis; nanomedicine; osteosarcoma; pediatric cancer; squalenoylgemcitabine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google